XML 26 R11.htm IDEA: XBRL DOCUMENT v3.24.3
Income Tax Expense
12 Months Ended
Jun. 30, 2024
Statement [LineItems]  
Income Tax Expense
NOTE 6. INCOME TAX EXPENSE
 
 
  
Consolidated
 
 
  
June 30, 2024
 
  
June 30, 2023
 
  
June 30, 2022
 
 
  
A$
 
  
A$
 
  
A$
 
Current tax
        
Current tax on profits for the fiscal year
     —         —         34  
  
 
 
    
 
 
    
 
 
 
Total current tax expense
     —         —      
 
34
 
  
 
 
    
 
 
    
 
 
 
Deferred income tax
        
Decrease in deferred tax assets
     (1,730,865      (2,326,468      244,144  
Decrease in deferred tax liabilities
     1,730,865        2,326,468        (244,144
  
 
 
    
 
 
    
 
 
 
Total deferred tax (benefit)/expense
     —         —         —   
  
 
 
    
 
 
    
 
 
 
Income tax expense
     —         —      
 
34
 
  
 
 
    
 
 
    
 
 
 
 
 
  
Consolidated
 
 
  
June 30, 2024
 
  
June 30, 2023
 
  
June 30, 2022
 
 
  
A$
 
  
A$
 
  
A$
 
Numerical reconciliation of income tax expense to prima facie tax expense
        
Loss before income tax expense
     (42,716,625      (39,896,348      (32,210,792
Tax at the Australian tax rate of 25% (2023 & 2022:25%)
     (10,679,156      (9,974,087      (8,052,698
Tax effect amounts which are not deductible/(taxable) in calculating taxable income:
        
Non-deductible
share-based payments
     449,072        500,393        371,710  
Other
non-deductible
expenses
     31,997        332,523        1,485,059  
Non-assessable
income
     (930,697      (828,500      (783,318
Deductible capital listing fee
     (834,683      (507,561      (368,398
Adjustment of current tax for prior period
     —         —         148,303  
Difference in overseas tax rates*
     6,542,761        5,442,226        4,118,372  
  
 
 
    
 
 
    
 
 
 
     (5,420,706      (5,035,006      (3,080,970
Net adjustment to deferred tax assets and liabilities for tax losses and temporary differences not recognized
     5,420,706        5,035,006        3,080,936  
  
 
 
    
 
 
    
 
 
 
Income tax expense**
     —         —      
 
(34
  
 
 
    
 
 
    
 
 
 
 
*
Difference in overseas tax rate is largely as a result of the corporate income tax rate of 10% applicable to the Immutep subsidiary in France for fiscal year 2024, 2023 and 2022.
**
Income tax expense relates to tax payable for the Immutep subsidiary in the United States.
 
 
  
Consolidated
 
 
  
June 30, 2024
 
  
June 30, 2023
 
  
June 30, 2022
 
 
  
A$
 
  
A$
 
  
A$
 
Deferred tax assets for tax losses not recognised comprises:
        
Unused tax losses for which no deferred tax asset has been recognized
     310,330,626        221,070,595        206,764,587  
  
 
 
    
 
 
    
 
 
 
Total deferred tax assets for tax losses not recognized
  
 
58,586,607
 
  
 
42,042,046
 
  
 
43,688,958
 
  
 
 
    
 
 
    
 
 
 
The above potential
 tax benefit for tax losses has not been
recognized
in the consolidated balance sheet as the recovery of this benefit is not probable. There is no expiration date for the tax losses carried forward. The estimated amount of cumulative tax losses at June 30, 2024 was $
310,330,626
(2023: $
221,070,595
,
 
2022: 206,764,587). 
Utilization
of these tax losses is dependent on the parent entity and its subsidiaries satisfying certain tests at the time the losses are recouped and in generating future taxable
profits
against
which to utilize the losses.